Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myopia, Degenerative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05894382
What this trial is testing

Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control

Who this might be right for
Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center 236
Not applicableEnrolling By InvitationNCT06221592
What this trial is testing

Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses

Who this might be right for
Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center 252
Not applicableLooking for participantsNCT05756959
What this trial is testing

Myopia Control Combined PBM With Myopic Defocus Lens in Children

Who this might be right for
Myopia, Progressive
Beijing Airdoc Technology Co., Ltd. 304
Not applicableWithdrawnNCT01256580
What this trial is testing

Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

Who this might be right for
Choroidal NeovascularizationMyopiaPunctate Inner Choroidopathy (PIC)+5 more
Massachusetts Eye and Ear Infirmary
Not applicableActive Not RecruitingNCT03818880
What this trial is testing

Choroidal Response to Novel Spectacle Lens to Control Myopia Progression

Who this might be right for
Myopia, Progressive
SightGlass Vision, Inc. 10
Large-scale testing (Phase 3)UnknownNCT01809223
What this trial is testing

A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV

Who this might be right for
Choroid Neovascularization Secondary to Degenerative Myopia
Chengdu Kanghong Biotech Co., Ltd. 176
Large-scale testing (Phase 3)Study completedNCT02034006
What this trial is testing

The Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

Who this might be right for
Choroidal Neovascularization Secondary to Pathologic Myopia
Novartis Pharmaceuticals 200
Not applicableUnknownNCT04561869
What this trial is testing

PIC and Its Role in Progression of Pathological Myopia

Who this might be right for
Punctate Inner Choroidopathy
Assiut University 39
Testing effectiveness (Phase 2)WithdrawnNCT02122159
What this trial is testing

Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration

Who this might be right for
Myopic Macular Degeneration
University of California, Los Angeles
Post-approval studies (Phase 4)Study completedNCT03409250
What this trial is testing

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Who this might be right for
Choroidal NeovascularizationAge Related Macular Degeneration
Vista Klinik 20
Early research (Phase 1)Study completedNCT01968486
What this trial is testing

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Who this might be right for
Myopia, Degenerative
University of Campania Luigi Vanvitelli 60
Not applicableNot Yet RecruitingNCT07291960
What this trial is testing

Retinal Clinical Assessment With AI-derived Quantitative Information

Who this might be right for
no Obvious AbnormalitiesDiabetic Retinopathy (DR)AMD+5 more
Beijing Tongren Hospital 29
Not applicableUnknownNCT05597163
What this trial is testing

Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents

Who this might be right for
Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center 588
Post-approval studies (Phase 4)Study completedNCT03042871
What this trial is testing

Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Zhongshan Ophthalmic Center, Sun Yat-sen University 54
Not applicableNot Yet RecruitingNCT06918028
What this trial is testing

An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings

Who this might be right for
Retinal DiseasesChoroidal DiseasePathological Myopia+3 more
Zhongshan Ophthalmic Center, Sun Yat-sen University 9,999
Not applicableLooking for participantsNCT06088225
What this trial is testing

Myopia Preventing With Distance-image Screen

Who this might be right for
Myopia, Progressive
Beijing Airdoc Technology Co., Ltd. 100
Not applicableUnknownNCT06071260
What this trial is testing

Effect of Atropine on Pupil Size and Quality of Vision

Who this might be right for
Myopia, Progressive
He Eye Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01037348
What this trial is testing

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

Who this might be right for
Choroidal Neovascularisation
Novartis 65
Not applicableUnknownNCT05331378
What this trial is testing

Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression

Who this might be right for
Myopia, ProgressiveMyopia
Essilor International 80
Not applicableWithdrawnNCT05773118
What this trial is testing

A Unified Index to Predict the Success Probability of Myopia Control

Who this might be right for
Myopia, Progressive
Nova Southeastern University
Next Page